“A fragmented AI regulatory map across the US will emerge fast,” said ... Enterprises can fall in line with compliance by ...

As artificial intelligence (AI) reshapes industries, its transformative potential comes with a complex web of regulatory ...

The global race to harness the power of artificial intelligence (AI) has begun. President Donald Trump got it right from the ...

Drug discovery has long been criticized for its slow, costly, and failure-prone nature. Traditional approaches, particularly ...

A terrific indication of AI’s promise is the 2024 Nobel Prize in chemistry, winners of which used AI to “crack the code” of ...

Jessica Copeland and Marc Krawiec explain that despite early provisions in the One Big Beautiful Bill Act to block state ...

As AI, model-based systems engineering and digital thread strategies evolve, they're transforming how organizations define ...

The visit—Huang’s third to China this year—coincided with a series of significant developments: regulatory approval for ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

U.S. President Donald Trump is slated to deliver a message outlining his vision for America's role in the development of ...